Management of osteosarcoma of the head and neck : Current Opinion in Otolaryngology & Head and Neck Surgery

Secondary Logo

Journal Logo

MAXILLOFACIAL SURGERY: Edited by Sherard Tatum and Ryan Winters

Management of osteosarcoma of the head and neck

Sharin, Florida; Pai, Ameya; Mair, Manish

Author Information
Current Opinion in Otolaryngology & Head and Neck Surgery 31(4):p 269-275, August 2023. | DOI: 10.1097/MOO.0000000000000900


Purpose of review 

There is no clear consensus guideline that specifies the optimum course of treatment for adult head and neck osteosarcoma (HNO) because of its rarity. The review's goal is to examine the most recent research on the presentation, diagnosis, prognosis, and therapy of head and neck osteosarcoma.

Recent findings 

Due to overlapping symptoms with various benign disorders of the lower jaw and midface bone, these patients present with a noticeable delay. The greatest results for these malignancies can be achieved with surgery with sufficient margins. However, it may not be able to achieve sufficient margins in tumours of the midface and skull base, and the significance of adjuvant radiation/chemotherapy needs to be investigated. The use of adjuvant radiation in instances with an advanced stage, poor prognostic indicators, and inadequate resection is supported by evidence. Nonetheless, there are divergent opinions regarding the advantages of chemotherapy in adjuvant and neoadjuvant conditions, and further multicentric randomized control trials are required to provide robust evidence.


Multimodality treatments seem to yield better results for advanced HNO with adverse features and incomplete resections.

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid